Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akeem Sanni

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Biomolecules|September 28, 2023
<i>N</i>-Glycome Profile of the Spike Protein S1: Systemic and Comparative Analysis from Eleven Variants of SARS-CoV-2Cristian D Gutierrez Reyes, Sherifdeen Onigbinde, Akeem Sanni, et al.
Biomolecules|March 29, 2023
LC-MS/MS-Based Proteomics Approach for the Identification of Candidate Serum Biomarkers in Patients with Narcolepsy Type 1Akeem Sanni, Mona Goli, Jingfu Zhao, et al.
Proteomics|July 18, 2025
Serum Proteome Profiling of Diabetic Patients Treated With DPP4 and SGLT2 Inhibitors Shows Improved Cognitive and Cardiovascular FunctionsMd Abdul Hakim, Akeem Sanni, Shams T Osman, et al.
British Journal of Pharmacology|January 26, 2026
Repurposing SGLT2 and DPP-4 inhibitors for mild cognitive impairment in type 2 diabetes mellitus: Insights from proteomics, target prediction and molecular dockingShams T Osman, Perihan A Elzahhar, Md Abdul Hakim, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Biomolecules|September 28, 2023
<i>N</i>-Glycome Profile of the Spike Protein S1: Systemic and Comparative Analysis from Eleven Variants of SARS-CoV-2Cristian D Gutierrez Reyes, Sherifdeen Onigbinde, Akeem Sanni, et al.
Biomolecules|March 29, 2023
LC-MS/MS-Based Proteomics Approach for the Identification of Candidate Serum Biomarkers in Patients with Narcolepsy Type 1Akeem Sanni, Mona Goli, Jingfu Zhao, et al.
Proteomics|July 18, 2025
Serum Proteome Profiling of Diabetic Patients Treated With DPP4 and SGLT2 Inhibitors Shows Improved Cognitive and Cardiovascular FunctionsMd Abdul Hakim, Akeem Sanni, Shams T Osman, et al.
British Journal of Pharmacology|January 26, 2026
Repurposing SGLT2 and DPP-4 inhibitors for mild cognitive impairment in type 2 diabetes mellitus: Insights from proteomics, target prediction and molecular dockingShams T Osman, Perihan A Elzahhar, Md Abdul Hakim, et al.
Pageof 2